Universitätsklinikum Essen

Further delineation of the SCAF4-associated neurodevelopmental disorder (2024) Schmid CM, Gregor A, Ruiz A, Manso Bazús C, Herman I, Ammouri F, Kotzaeridou U, et al. Journal article High interobserver variability of PTEN immunohistochemistry defining PTEN status in low- to intermediate-risk prostate cancer: results of the first German ring trial (2024) Hommerding O, Bernhardt M, Kreft T, Scherping A, Abbas M, Baretton G, Bräsen JH, et al. Journal article CT-Defined Pectoralis Muscle Density Predicts 30-Day Mortality in Hospitalized Patients with COVID-19: A Nationwide Multicenter Study (2024) Bucher AM, Behrend J, Ehrengut C, Müller L, Emrich T, Schramm D, Akinina A, et al. Journal article Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial. (2024) Meyer S, Bay J, Franz AR, Ehrhardt H, Klein L, Petzinger J, Binder C, et al. Journal article Was braucht es, um forschungsfit zu sein? Fokusgruppendiskussionen mit Hausärzt*innen und Medizinischen Fachangestellten (2024) Wolf F, Klanke M, Klein AA, Kuschick D, Lingner H, Löscher S, Stark S, Mergenthal K Journal article The Microbiome Modifies Manifestations of Hemophagocytic Lymphohistiocytosis in Perforin-Deficient Mice (2024) Mann J, Runge S, Schell C, Gräwe K, Thoulass G, Lao J, Ammann S, et al. Journal article Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas With Simultaneously Integrated Boost and Protection: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery (2024) Moustakis C, Blanck O, Grohmann M, Albers D, Bartels D, Bathen B, Borzì GR, et al. Journal article Pre-treatment metastatic biopsy: a step towards precision oncology for urothelial cancer (2024) Klümper N, Cox A, Sjödahl G, Roghmann F, Bolenz C, Hartmann A, Grünwald V, et al. Journal article, Review article A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 (2024) Hughes BG, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, et al. Journal article Single or Double Induction With 7 1 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia (2024) Röllig C, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, Hänel M, et al. Journal article